Lv4
570 积分 2023-08-09 加入
Tumour and microenvironment crosstalk in NSCLC progression and response to therapy
1个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
1个月前
已完结
Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases
2个月前
已完结
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancer
2个月前
已完结
Metastatic Trajectories in Non–Small Cell Lung Cancer Guide Local and Systemic Therapies
2个月前
已完结
KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer
2个月前
已完结
Proteomic landscape of pan-tissue neuroendocrine carcinomas defines subtype-specific functional architectures, biomarkers and therapeutic targets
2个月前
已完结
IL-6 drives chemoimmunotherapy resistance in NSCLC by reprogramming myeloid cells and impairing cytotoxic lymphocyte function
2个月前
已完结
Integrated Multi-Omics Analyses Identified the H3k18la-Based Spatiotemporal Characteristics and Risk-Stratified Treatment Strategy in Lung Adenocarcinoma
2个月前
已完结
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2个月前
已完结
皖公网安备34019202002308
